Thursday, March 13, 2014

Neurologist Claims There Is No Such Thing as ADHD



Neurologist Claims There Is No Such Thing as ADHD

by Robert Wilde 11 Mar 2014, 11:56 AM PDT
Dr. Richard Saul, a behavioral neurologist based in Chicago, has made an interesting observation about the squirming, unfocused children brought to his office by desperate parents who beg him to ease their child’s ADHD behavior. After 50 years of practicing medicine and seeing thousands of patients demonstrating symptoms of Attention Deficit Hyperactivity Disorder, Dr Saul’s observation is that: ADHD doesn’t exist.

More than ten percent of American children have been diagnosed with the disorder, and it is now considered the most common mental health disorder in the United Kingdom. Unfortunately, the drug that has been most often prescribed for the condition, Ritalin, which was designed to stimulate the brain and reduce fidgeting, proves to sometimes exacerbate the condition and creates its own matrix of side effects, including dangerous behavior. According to Dr. Saul,  treating so called ADHD behavior with stimulants is neglectful and wrong.

In the 70s, Saul believed in ADHD; however, he has come to the conclusion that an array of childhood attention disorders may be rooted in nutritional deficiencies. In many situations, iron deficiency (otherwise known as anemia) can produce fatigue, poor attention and concentration, and memory problems. Once iron was added to the diet with iron pills and more fish, fruit, vegetables, and nuts, performance and behavior improved. Significantly, a 2004 French study discovered that 84% of children diagnosed with ADHD were iron deficient, compared to only 18% of children that were not diagnosed with the alleged disease.

Dr. Saul has identified up to twenty diseases that have been misdiagnosed as ADHD, including Tourette syndrome, obsessive compulsive disorder, and schizophrenia. He believes that people who think they have  ADHD or some other condition are dealing with a normal level of stress in a faster-paced world. The doctor recommends that changing your lifestyle, eating better, getting exercise, and sleeping more will mitigate the symptoms normally associated with ADHD.

Methylphenidate (Ritalin)
Methylphenidate (trade names Concerta, Methylin, Ritalin, Equasym XL) is a psychostimulant drug and substituted phenethylamine approved for treatment of attention-deficit hyperactivity disorder (ADHD), postural orthostatic tachycardia syndrome and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation. It was first licensed by the U.S. Food and Drug Administration (FDA) in 1955 for treating what was then known as hyperactivity. Prescribed to patients beginning in 1960, the drug became heavily prescribed in the 1990s, when the diagnosis of ADHD itself became more widely accepted.

Novartis Corporation
Novartis Corporation is a U.S. subsidiary of Novartis AG, and a member of the Pharmaceutical Research and Manufacturers of America.

Note: Akin, Gump, Strauss, Hauer & Feld, LLP is the lobby firm for the Novartis Corporation, and the Pharmaceutical Research and Manufacturers of America.
James F. Collins was a senior advisor for Akin, Gump, Strauss, Hauer & Feld, LLP, and is a senior associate at the Carnegie Endowment for International Peace (think tank).
William W. George is a trustee at the Carnegie Endowment for International Peace (think tank), and was a director at Novartis AG.
Daniel Vasella was the chairman for Novartis AG, and is a trustee at the Carnegie Endowment for International Peace (think tank).
Carnegie Endowment for International Peace (think tank) was a funder for the Nuclear Threat Initiative (think tank).
Margaret A. Hamburg is a VP for the Nuclear Threat Initiative (think tank), and the commissioner for the U.S. Food and Drug Administration (FDA).
Jessica Tuchman Mathews is a director at the Nuclear Threat Initiative (think tank), the president of the Carnegie Endowment for International Peace (think tank), a director at the American Friends of Bilderberg (think tank), was an honorary trustee at the Brookings Institution (think tank), and a 2008 Bilderberg conference participant (think tank).
Ed Griffin’s interview with Norman Dodd in 1982
(The investigation into the Carnegie Endowment for International Peace uncovered the plans for population control by involving the United States in war)
Foundation to Promote Open Society was a funder for the Carnegie Endowment for International Peace (think tank), and the Brookings Institution (think tank).
George Soros was the chairman for the Foundation to Promote Open Society.
Donald Kennedy was a trustee at the Carnegie Endowment for International Peace (think tank), and a commissioner for the U.S. Food and Drug Administration (FDA).
Mark B. McClellan was a senior fellow at the Brookings Institution (think tank), and a commissioner for the U.S. Food and Drug Administration (FDA).
Ann M. Fudge is a trustee at the Brookings Institution (think tank), and a director at Novartis AG.
Marjorie M.T. Yang is a director at Novartis AG, and was a trustee at the Conference Board.
Klaus Kleinfeld is a trustee at the Brookings Institution (think tank), a trustee at the Conference Board (think tank), a director at Bayer AG, and a 2008 Bilderberg conference participant (think tank).
Bayer AG
The Bayer company then became part of IG Farben, a German chemical company conglomerate. During World War II, the IG Farben used slave labor in factories attached to large slave labor camps, notably the sub-camps of the Mauthausen-Gusen concentration camp.[3] IG Farben owned 42.5% of the company that manufactured Zyklon B,[4] a chemical used in the gas chambers of Auschwitz and other extermination camps. After World War II, the Allies broke up IG Farben and Bayer reappeared as an individual business. The Bayer executive Fritz ter Meer, sentenced to seven years in prison during the IG Farben Military Tribunal at Nuremberg, was made head of the supervisory board of Bayer in 1956, after his release.
Bayer Corporation is the North American subsidiary of Bayer AG.
Mayer Brown was the lobby firm for the Bayer Corporation.
William M. Daley 
Professional career 
Daley returned to the practice of law, as a partner with the firm Mayer Brown (then Mayer, Brown & Platt) from 1993 to 1997.
William M. Daley was a partner at Mayer Brown, the chief of staff for the Barack Obama administration, and is a member of the Commercial Club of Chicago.
Robert A. Helman is a partner at Mayer Brown, a member of the Commercial Club of Chicago, and was an honorary trustee at the Brookings Institution (think tank).
Cyrus F. Freidheim Jr. is an honorary trustee at the Brookings Institution (think tank), and a member of the Commercial Club of Chicago.
Newton N. Minow is a member of the Commercial Club of Chicago, and a senior counsel at Sidley Austin LLP.
R. Eden Martin is the president of the Commercial Club of Chicago, and counsel at Sidley Austin LLP
Michelle Obama was a lawyer at Sidley Austin LLP.
Barack Obama was an intern at Sidley Austin LLP.
Sidley Austin LLP is the lobby firm for Bayer HealthCare.
Bayer HealthCare is a subsidiary of Bayer AG.





No comments: